Introduction
Anaplastic Astrocytoma - Overview
Anaplastic Astrocytoma - Therapeutics Development
Anaplastic Astrocytoma - Therapeutics Assessment
Anaplastic Astrocytoma - Companies Involved in Therapeutics Development
Anaplastic Astrocytoma - Drug Profiles
Anaplastic Astrocytoma - Dormant Projects
Anaplastic Astrocytoma - Discontinued Products
Anaplastic Astrocytoma - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Anaplastic Astrocytoma, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Anaplastic Astrocytoma - Pipeline by AbbVie Inc, H1 2020
Anaplastic Astrocytoma - Pipeline by Adastra Pharmaceuticals Inc, H1 2020
Anaplastic Astrocytoma - Pipeline by Aduro BioTech Inc, H1 2020
Anaplastic Astrocytoma - Pipeline by Aettis Inc, H1 2020
Anaplastic Astrocytoma - Dormant Projects, H1 2020
Anaplastic Astrocytoma - Dormant Projects, H1 2020 (Contd..1), H1 2020
Anaplastic Astrocytoma - Discontinued Products, H1 2020

List of Figures
Number of Products under Development for Anaplastic Astrocytoma, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020

Companies Mentioned
• AbbVie Inc
• Adastra Pharmaceuticals Inc
• Aduro BioTech Inc
• Aettis Inc
• AngioChem Inc
• Apexigen Inc
• Astellas Pharma Inc
• Bayer AG
• Berg LLC
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Co
• Calithera Biosciences Inc
• Candel Therapeutics
• CDG Therapeutics Inc
• Deciphera Pharmaceuticals Inc
• Everfront Biotech Inc
• Ipsen SA
• Kazia Therapeutics Ltd
• Mustang Bio Inc
• Novartis AG
• Orbus Therapeutics Inc
• Pfizer Inc
• PTC Therapeutics Inc
• Taiho Oncology Inc
• TheraBiologics Inc
• Vanquish Oncology Inc
• Wayshine Biopharma Inc
• ZIOPHARM Oncology Inc